Published 2 days ago • loading... • Updated 1 day ago

China’s biotech firms record surge in overseas licensing deals in first quarter

Summary by South China Morning Post

Chinese drug makers landed 33 licensing deals with overseas pharmaceutical firms, with transactions totalling US$36.2 billion.

3 Articles

All

Left

Center

Right

South China Morning Post

Center

China’s biotech firms record surge in overseas licensing deals in first quarter

Chinese drug makers landed 33 licensing deals with overseas pharmaceutical firms, with transactions totalling US$36.2 billion.

1 day ago·Hong Kong

Read Full Article

Express Pharma

Pharma funding rises 81 per cent in march 2025, late-stage deals lead - Express Pharma

According to Tracxn’s latest report, funding in the pharma and healthcare sector has increased by 81.38 per cent to $79 million in March 2025, up from $43.5 million in February 2025. However, this marks a 50.06 per cent decline compared to the $158 million raised in March 2024. Late-stage funding accounted for the majority of investments, contributing $61.4 million, or 77.8 per cent of the total. Seed-stage funding amounted to $16.8 million, mak…

2 days ago

Read Full Article